Follow
Carolyn A. Young
Carolyn A. Young
Clinical Professor of Neurology, University of Liverpool
Verified email at thewaltoncentre.nhs.uk
Title
Cited by
Cited by
Year
A controlled trial of Natalizumab for relapsing multiple sclerosis
DH Miller, OA Khan, WA Sheremata, LD Blumhardt, GP Rice, MA Libonati, ...
New England Journal of Medicine 348 (1), 15-23, 2003
15552003
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
DJ Rog, TJ Nurmikko, T Friede, CA Young
Neurology 65 (6), 812-819, 2005
8302005
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind …
G Comi, V Martinelli, M Rodegher, L Moiola, O Bajenaru, A Carra, ...
The Lancet 374 (9700), 1503-1511, 2009
7822009
Achieving saturation in thematic analysis: Development and refinement of a codebook
H Ando, R Cousins, C Young
Comprehensive Psychology 3 (Article 4), 2014
7432014
Randomized controlled trial of interferon-beta-1a in secondary progressive MS: clinical results
Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta ...
Neurology 56 (11), 1496-1504, 2001
4912001
Placebo-controlled trial of oral laquinimod for multiple sclerosis
FM Comi G, Jeffery D, Kappos L, Montalban X, Boyko A, Rocca MA, ...
New England journal of medicine 366 (11), 1000-9, 2012
4422012
The effect of anti-α4 integrin antibody on brain lesion activity in MS
N Tubridy, PO Behan, R Capildeo, A Chaudhuri, R Forbes, CP Hawkins, ...
Neurology 53 (3), 466-466, 1999
4111999
Anti‐spasticity agents for multiple sclerosis
D Shakespeare, M Boggild, CA Young, ...
Cochrane Database of Systematic Reviews 2010 (1), 1996
3951996
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled …
G Comi, A Pulizzi, M Rovaris, O Abramsky, T Arbizu, A Boiko, R Gold, ...
Lancet 371 (9630), 2085-92, 2008
3512008
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open …
R Kapoor, PR Ho, N Campbell, I Chang, A Deykin, F Forrestal, N Lucas, ...
The Lancet Neurology 17 (5), 405-415, 2018
3182018
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS
LRMSSG Polman C, Barkhof F, Sandberg-Wollheim M, Linde A, Nordle O, Nederman T
Neurology 64 (6), 987-991, 2005
3142005
Oromucosal Δ9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial
DJ Rog, TJ Nurmikko, CA Young
Clinical therapeutics 29 (9), 2068-2079, 2007
2872007
Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group.
McGuigan C, Craner M, Guadagno J, Kapoor R, Mazibrada G, Molyneux P ...
J Neurol Neurosurg Psychiatry 87 (2), 117-25, 2016
2722016
Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis
N Scolding, D Barnes, S Cader, J Chataway, A Chaudhuri, A Coles, ...
Practical neurology 15 (4), 273-279, 2015
2542015
A medical definition of fatigue in multiple sclerosis
RJ Mills, CA Young
QJM: An International Journal of Medicine 101 (1), 49-60, 2008
2222008
Treatment for ataxia in multiple sclerosis
RJ Mills, L Yap, CA Young
Cochrane Database of Systematic Reviews, 2007
1962007
Quality of life in multiple sclerosis in France, Germany, and the United Kingdom
N Murphy, C Confavreux, J Haas, N König, E Roullet, M Sailer, M Swash, ...
Journal of Neurology, Neurosurgery & Psychiatry 65 (4), 460-466, 1998
1751998
A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment
J Craig, CA Young, M Ennis, G Baker, M Boggild
Journal of Neurology, Neurosurgery & Psychiatry 74 (9), 1225-1230, 2003
1722003
Perceptions of self-efficacy and rehabilitation among neurologically disabled adults
G Dixon, EW Thornton, CA Young
Clinical rehabilitation 21 (3), 230-240, 2007
1702007
The relationship between fatigue and other clinical features of multiple sclerosis
RJ Mills, CA Young
Multiple Sclerosis Journal 17 (5), 604-612, 2011
1502011
The system can't perform the operation now. Try again later.
Articles 1–20